Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Topical treatment 'can be effective'
Clinical studies show that topical treatment alone can be as effective as giving antibiotic tablets.

BSAVA delegates learn how to limit the spread of MRSA/MRSP

MRSA and MRSP present an increasing risk to both animals and humans. Speaking at BSAVA Congress (6-9 April), Dr Anette Loeffler, senior lecturer in veterinary dermatology at the RVC, outlined the infections and discussed the most appropriate control strategies to limit their spread.  

MRSA and MRSP are very different diseases, but they are most often identified from skin and ear infections. While the prognosis is usually very good, they both have zoonotic implications and the growing crisis of antibiotic resistance means that treatment options are limited.

MRSA is primarily a human pathogen, also known as the human hospital bug. Around 10 years ago, MRSA could be found in almost every human hospital in the UK. While rates have fallen dramatically, it is still one of the most important hospital-associated bacterial pathogens. In pets, MRSA tends to be a spillover from human hospitals.

MRSP is the veterinary equivalent of MRSA and has the potential to become a veterinary nosocomial pathogen. "This is where we've all got responsibility to nip it in the bud," said Anette. MRSP infections appear to be increasing in animals, especially dogs. The infection transmits to pets by direct contact between animals. Healthy animals showing no signs of MRSP infection are likely to be the main source of the bacterium.

The risk of contracting MRSA or MRSP increases through long stays in clinics, invasive procedures, use of implants and the prolonged use of invasive equipment such as a catheter. Veterinary staff have a higher occupational risk of carrying MRSA. Veterinary practices are also likely to harbour more resistant bacteria than the home, but only if hygiene practices are below standard.

During the lecture, Anette gave delegates some take-home tips to prevent and control MRSA and MRSP infection amongst pets and within veterinary practices. She stressed that owner education, maintaining good practice hygiene and the responsible use of antimicrobials are key to preventing the spread of infection.

Anette also highlighted the importance of hand washing using staphylococcal agents and to follow the manufacturer's protocols of cleaning and disinfection. Infected animals shed the virus into the environment, so they should be treated as contagious patients, she said. Hospitalised patients must be isolated or barrier nursed and appointments should be scheduled for the end of the day.

Her final tip was to recognise signs of MRSA and MRSP in patients early and to encourage them to follow up with topical treatment (washing). Clinical studies show that topical treatment alone can be as effective as giving antibiotic tablets. But Anette stressed that this requires an element of owner compliance and understanding.

"All of us need to work very hard to convince owners that topical treatment can be effective," she concluded.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.